Andri Signorell

Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease

Christoph Höck, Uwe Konietzko, Johannes Streffer et al. · Neuron · 2003 · 777 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Neurology +4

Treatment with the selective muscarinic ml agonist talsaclidine decreases cerebrospinal fluid levels of Aβ₄₂in patients with Alzheimer's disease

Christoph Höck, Alessia Maddalena, A. Raschig et al. · Amyloid · 2003 · 109 citations

Cerebrospinal Fluid Profile of Amyloid β Peptides in Patients with Alzheimer’s Disease Determined by Protein Biochip Technology

Alessia Maddalena, Andreas Papassotiropoulos, Charo Gonzalez-Agosti et al. · Neurodegenerative Diseases · 2004 · 73 citations · Full text

Neurochemical Biomarkers, Protein Biochip Technology, Alzheimer's Disease +22

Place of death and health care utilization for people in the last 6 months of life in Switzerland: a retrospective analysis using administrative data

Oliver Reich, Andri Signorell, André Busato · BMC Health Services Research · 2013 · 59 citations · Full text

Improved prediction of medical expenditures and health care utilization using an updated chronic disease score and claims data

Carola A. Huber, Sebastian Schneeweiß, Andri Signorell et al. · Journal of Clinical Epidemiology · 2013 · 56 citations

Disease Management, Primary Care, Health Informatics +14